Back to Rounds
Series B Round
Funding Details
CureGene Pharma focuses on therapeutic areas including cardiovascular and metabolic diseases, developing innovative therapies to improve patient outcomes. The company aims to leverage cutting-edge research and technology to create effective treatments that address unmet medical needs in these critical health areas.
Confidence Score
Participating Investors
No investors recorded for this funding round.
Related Tweets
No tweets found for this funding round.